Rhophylac

Hauptinformation

  • Handelsname:
  • Rhophylac 300 Mikrogramm/2 ml - Injektionslösung in einer Fertigspritze
  • Darreichungsform:
  • Injektionslösung
  • Zusammensetzung:
  • Anti-D-Immunglobulin vom Menschen 1500I.E.
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Rhophylac 300 Mikrogramm/2 ml - Injektionslösung in einer Fertigspritze
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • PEI.H.11819.01.1
  • Letzte Änderung:
  • 03-12-2017

27-3-2018

Dringende Sicherheitsinformation zu Monoclonal Mouse, Anti-Pneumocystis J. & Anti Huma von Dako Denmark A/S

Dringende Sicherheitsinformation zu Monoclonal Mouse, Anti-Pneumocystis J. & Anti Huma von Dako Denmark A/S

Weitere Informationen sowie Details zum Produkt entnehmen Sie bitte der anliegenden Kundeninformation des Herstellers.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

26-2-2018

FDA Drug Safety Communication: FDA determines 2013 labeling adequate to manage risk of retinal abnormalities, potential vision loss, and skin discoloration with anti-seizure drug Potiga (ezogabine); requires additional study

FDA Drug Safety Communication: FDA determines 2013 labeling adequate to manage risk of retinal abnormalities, potential vision loss, and skin discoloration with anti-seizure drug Potiga (ezogabine); requires additional study

[06-16-2015] Based on reviews of additional safety reports from patients treated with the anti-seizure drug Potiga (ezogabine), the U.S. Food and Drug Administration (FDA) has determined that the potential risks of vision loss due to pigment changes in the retina and of skin discoloration can be adequately managed by following the current recommendations in the Potiga labeling.

FDA - U.S. Food and Drug Administration

16-11-2017

FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes

FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes

[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAIDs are available by prescription and OTC. E...

FDA - U.S. Food and Drug Administration

30-8-2017

Lucky Mart Inc. Issues Voluntary Nationwide Recall Of Piyanping Anti-Itch Lotion Due to Incorrect Active Ingredient

Lucky Mart Inc. Issues Voluntary Nationwide Recall Of Piyanping Anti-Itch Lotion Due to Incorrect Active Ingredient

Lucky Mart Inc. is voluntarily recalling lots C14005, C16001 and C16002 of Piyanping Anti-Itch Lotion to the consumer level. The product was manufactured using the active pharmaceutical ingredient dexamethasone rather than hydrocortisone. Dexamethasone is not listed as an ingredient in the labeling.

FDA - U.S. Food and Drug Administration

28-3-2018

Anti-Vaccine Movement Affecting Kids With Autism

Anti-Vaccine Movement Affecting Kids With Autism

Title: Anti-Vaccine Movement Affecting Kids With AutismCategory: Health NewsCreated: 3/26/2018 12:00:00 AMLast Editorial Review: 3/27/2018 12:00:00 AM

US - MedicineNet

27-2-2018

Lamictal vs. Abilify

Lamictal vs. Abilify

Lamictal (lamotrigine) and Abilify (aripiprazole) are used to treat bipolar disorders. Lamictal is also used alone or in combination with other anti-seizure medications for treating certain types of seizures. Abilify is also used to treat schizophrenia, mania, depression, bipolar disorders, autistic disorder, and some irritable behavior disorders. Lamictal and Abilify belong to different drug classes. Lamictal is an anticonvulsant (anti-seizure) and Abilify is an antipsychotic.

US - RxList

27-2-2018

Lamictal vs. Neurontin

Lamictal vs. Neurontin

Lamictal (lamotrigine) and Neurontin (gabapentin) are anticonvulsants (anti-seizure drugs) used alone or in combination with other anti-seizure medications for treating certain types of seizures. Neurontin is also used to treat nerve pain caused by shingles (herpes zoster).

US - RxList

3-2-2018

'Anti-Vaxxers' Are Often Conspiracy Theorists, Too

'Anti-Vaxxers' Are Often Conspiracy Theorists, Too

Title: 'Anti-Vaxxers' Are Often Conspiracy Theorists, TooCategory: Health NewsCreated: 2/1/2018 12:00:00 AMLast Editorial Review: 2/2/2018 12:00:00 AM

US - MedicineNet

30-1-2018

Anti-Smoking Group With Tobacco Ties

Anti-Smoking Group With Tobacco Ties

Title: Anti-Smoking Group With Tobacco TiesCategory: Health NewsCreated: 1/26/2018 12:00:00 AMLast Editorial Review: 1/29/2018 12:00:00 AM

US - MedicineNet

17-1-2018

Health Tip: Using Anti-Lock Brakes

Health Tip: Using Anti-Lock Brakes

Title: Health Tip: Using Anti-Lock BrakesCategory: Health NewsCreated: 1/16/2018 12:00:00 AMLast Editorial Review: 1/16/2018 12:00:00 AM

US - MedicineNet

1-1-2018

01.01.2018: Benlysta 120 mg, Pulver zur Herstellung einer Infusionslösung, Durchstechflasche(n), 216.70, -9.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer61532001 PSZulassungsinhaberGlaxoSmithKline AGNameBenlysta 120 mg, Pulver zur Herstellung einer InfusionslösungRegistrierungsdatum14.06.2012  Erstzulassung Sequenz14.06.2012ATC-KlassierungBelimumab (L04AA26)Revisionsdatum WHOWHO-DDDGültig bis13.06.2022Index Therapeuticus (BSV)07.15.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.15.Beschreibung AbgabekategorieA  SL EintragJaAnwendungSystemischer Lupus ery...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung, Durchstechflasche(n), 684.10, -10.2%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer61532002 PSZulassungsinhaberGlaxoSmithKline AGNameBenlysta 400 mg, Pulver zur Herstellung einer InfusionslösungRegistrierungsdatum14.06.2012  Erstzulassung Sequenz14.06.2012ATC-KlassierungBelimumab (L04AA26)Revisionsdatum WHOWHO-DDDGültig bis13.06.2022Index Therapeuticus (BSV)07.15.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.15.Beschreibung AbgabekategorieA  SL EintragJaAnwendungSystemischer Lupus ery...

ODDB -Open Drug Database

18-12-2017

Neurontin vs. Xanax

Neurontin vs. Xanax

Neurontin (gabapentin) is an anti-epileptic medication used to treat seizures. Neurontin is used alone or in combination with other medications to treat seizures caused by epilepsy in adults and children who are at least 12 years old. Neurontin is also used to treat nerve pain caused by shingles (herpes zoster). Xanax (alprazolam) is a benzodiazepine used as an anti-anxiety medication prescribed to treat panic attacks and anxiety disorders.

US - RxList

16-12-2017

Graphic Anti-Smoking Ads Can Backfire on Kids

Graphic Anti-Smoking Ads Can Backfire on Kids

Title: Graphic Anti-Smoking Ads Can Backfire on KidsCategory: Health NewsCreated: 12/14/2017 12:00:00 AMLast Editorial Review: 12/15/2017 12:00:00 AM

US - MedicineNet

15-11-2017

Top Anti-Opioid Meds Are Equally Safe, Effective

Top Anti-Opioid Meds Are Equally Safe, Effective

Title: Top Anti-Opioid Meds Are Equally Safe, EffectiveCategory: Health NewsCreated: 11/15/2017 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM

US - MedicineNet

1-8-2017

Pau D'arco

Pau D'arco

Pau d'arco is an herbal supplement claimed to be anti-cancer and antimicrobial, especially anti-candida.

US - RxList